CH0012627250
© EQS Newswire
21.10.2024
HBMN
LISTED
SIX
HBM Healthcare Investments publishes Half-Year Report as at 30 September 2024 with key figures for the first six months of the 2024/2025 financial year
News Preview
Profit of CHF 23 million
NAV up by 1.5 percent and share price up by 1.7 percent
Private as well as public portfolio companies contribute to earnings
Unfavourable currency movements impact performance by almost 5 percent
Successful first half – currency effects impact performance
HBM Healthcare Investments generated a profit of CHF 23 milli......
Themefolio
Profiler
Peergroup
© EQS Newswire
21.10.2024
HBMN
LISTED
SIX
HBM Healthcare Investments erzielt im ersten Halbjahr des Geschäftsjahres 2024/2025 einen Gewinn von CHF 23 Millionen; Währungseffekte belasteten Ergebnis stark
News Preview
Gewinn von CHF 23 Millionen
NAV steigt um 1.5 Prozent und Aktienkurs um 1.7 Prozent
Private und börsenkotierte Portfoliounternehmen tragen zum Gewinn bei
Ungünstige Währungsentwicklungen belasten Performance mit knapp 5 Prozent
Erfolgreiches Halbjahr – Währungseffekte schmälern Performance
HBM Healthcare Investments erzielte in den ersten ......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2024
HBMN
LISTED
SIX
Key Figures
15.10.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.10.2024
16.10.2024 / 17:47 CET/CEST
in CHF
Performance in %
15.10.2024
MTD
FYTD
CYTD
NAV
249.16
2.0
3.4
......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© EQS Newswire
14.10.2024
HBMN
LISTED
SIX
HBM portfolio company Upstream Bio raises USD 255 million in successful initial public offering
News Preview
HBM Healthcare Investments AG
/ Key word(s): IPO
HBM portfolio company Upstream Bio raises USD 255 million in successful initial public offering
14.10.2024 / 06:30 CET/CEST
Upstream Bio (Nasdaq: UPB), a previously private company in the HBM Healthcare Investments portfolio, got off to a successful start on the stock m......
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© EQS Newswire
14.10.2024
HBMN
LISTED
SIX
Erfolgreicher Börsengang des HBM-Portfoliounternehmens Upstream Bio; Kapitalaufnahme von USD 255 Millionen
News Preview
HBM Healthcare Investments AG
/ Schlagwort(e): Börsengang
Erfolgreicher Börsengang des HBM-Portfoliounternehmens Upstream Bio; Kapitalaufnahme von USD 255 Millionen
14.10.2024 / 06:30 CET/CEST
Upstream Bio (Nasdaq: UPB), ein bisher privates Unternehmen aus dem Portfolio von HBM Healthcare Investments, legte am vergang......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2024
HBMN
LISTED
SIX
Key Figures
30.9.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
30.9.2024
01.10.2024 / 17:47 CET/CEST
in CHF
Performance in %
30.09.2024
MTD
FYTD
CYTD
NAV
244.34
5.6
1.5
......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2024
HBMN
LISTED
SIX
HBM Healthcare Investments erzielt im ersten Halbjahr des Geschäftsjahres 2024/2025 einen Gewinn von CHF 23 Millionen; Währungseffekte belasteten Ergebnis stark
News Preview
HBM Healthcare Investments hat in der ersten Hälfte des Geschäftsjahrs 2024/2025 eine positive Performance erzielt. Der innere Wert je Aktie (NAV) stieg um 1.5 Prozent auf CHF 244.34. Der Aktienkurs legte um 1.7 Prozent auf CHF 189.40 zu.
Auf Basis des ausgewiesenen NAV erwartet die Gesellschaft einen Halbjahresgewinn von rund CHF 23 Millionen (V......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2024
HBMN
LISTED
SIX
HBM Healthcare Investments posts half-year profit of CHF 23 million for 2024/2025 financial year; currency effects had a strong negative impact on the result
News Preview
HBM Healthcare Investments achieved a positive performance in the first half of the 2024/2025 financial year. The net asset value per share (NAV) increased by 1.5 per cent to CHF 244.34. The share price rose by 1.7 per cent to CHF 189.40.
Based on the reported NAV, the company expects a half-year profit of around CHF 23 million (previous year: los......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.09.2024
HBMN
LISTED
SIX
Key Figures
15.9.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.9.2024
16.09.2024 / 17:47 CET/CEST
in CHF
Performance in %
15.09.2024
MTD
FYTD
CYTD
NAV*
229.03
-1.0
-4.7
......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.09.2024
HBMN
LISTED
SIX
Key Figures
15.9.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.9.2024
16.09.2024 / 17:47 CET/CEST
in CHF
Performance in %
15.09.2024
MTD
FYTD
CYTD
NAV*
229.03
-1.0
-4.7
......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.09.2024
HBMN
LISTED
SIX
Key Figures
31.8.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
31.8.2024
02.09.2024 / 17:46 CET/CEST
in CHF
Performance in %
31.08.2024
MTD
FYTD
CYTD
NAV*
231.29
-1.8
-3.8
......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.08.2024
HBMN
LISTED
SIX
Key Figures
15.8.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.8.2024
16.08.2024 / 17:47 CET/CEST
in CHF
Performance in %
15.08.2024
MTD
FYTD
CYTD
NAV*
232.50
-1.3
-3.3
......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
02.08.2024
HBMN
LISTED
SIX
Key Figures
31.7.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
31.7.2024
02.08.2024 / 17:46 CET/CEST
in CHF
Performance in %
31.07.2024
MTD
FYTD
CYTD
NAV
243.25
-3.5
-2.0
......
Themefolio
Profiler
Peergroup
© EQS Newswire
19.07.2024
HBMN
LISTED
SIX
HBM Healthcare Investments publishes Quarterly Report as at 30 June 2024 with key figures for the first three months of the 2024/2025 financial year
News Preview
Quarterly profit of CHF 26 million
NAV increases by 1.6 percent and share price rises by 5.9 percent
Private portfolio companies as value drivers
Positive start to the new financial year
HBM Healthcare Investments started the new 2024/2025 financial year with a quarterly profit of CHF 26 million. The net asset value per share (NAV) rose by ......
Themefolio
Profiler
Peergroup
© EQS Newswire
19.07.2024
HBMN
LISTED
SIX
HBM Healthcare Investments publiziert Quartalsbericht per 30. Juni 2024 mit Kennzahlen für die ersten drei Monate des Geschäftsjahrs 2024/2025
News Preview
Quartalsgewinn von CHF 26 Millionen
NAV steigt um 1.6 Prozent und Aktienkurs um 5.9 Prozent
Private Portfoliounternehmen als Werttreiber
Positiver Start ins neue Geschäftsjahr
HBM Healthcare Investments startete mit einem Quartalsgewinn von CHF 26 Millionen in das neue Geschäftsjahr 2024/2025. Der innere Wert je Aktie (NAV) stieg in diesen ......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.07.2024
HBMN
LISTED
SIX
Key Figures
15.7.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.7.2024
16.07.2024 / 17:46 CET/CEST
in CHF
Performance in %
15.07.2024
MTD
FYTD
CYTD
NAV
251.97
0.0
1.6
......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.07.2024
HBMN
LISTED
SIX
Key Figures
30.06.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
30.06.2024
01.07.2024 / 17:46 CET/CEST
in CHF
Performance in %
30.06.2024
MTD
FYTD
CYTD
NAV
252.07
-1.8
1.6
......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2024
HBMN
LISTED
SIX
Generalversammlung der HBM Healthcare Investments stimmt allen Anträgen des Verwaltungsrats zu
News Preview
HBM Healthcare Investments AG
/ Schlagwort(e): Generalversammlung
Generalversammlung der HBM Healthcare Investments stimmt allen Anträgen des Verwaltungsrats zu
17.06.2024 / 17:53 CET/CEST
Die Aktionärinnen und Aktionäre haben an der heutigen ordentlichen Generalversammlung der HBM Healthcare Investments AG allen Antr......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2024
HBMN
LISTED
SIX
Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
News Preview
HBM Healthcare Investments AG
/ Key word(s): AGMEGM
Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
17.06.2024 / 17:53 CET/CEST
At today’s ordinary Shareholders’ Meeting of HBM Healthcare Investments Ltd the shareholders approved al......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2024
HBMN
LISTED
SIX
Key Figures
15.06.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.06.2024
17.06.2024 / 17:46 CET/CEST
in CHF
Performance in %
15.06.2024
MTD
FYTD
CYTD
NAV
251.13
-2.2
1.2
......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2024
HBMN
LISTED
SIX
Key Figures
15.06.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.06.2024
17.06.2024 / 17:46 CET/CEST
in CHF
Performance in %
15.06.2024
MTD
FYTD
CYTD
NAV
251.13
-2.2
1.2
......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.06.2024
HBMN
LISTED
SIX
Key Figures
31.05.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
31.05.2024
03.06.2024 / 17:46 CET/CEST
in CHF
Performance in %
31.05.2024
MTD
FYTD
CYTD
NAV
256.74
0.8
3.5
......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
HBMN
LISTED
SIX
HBM-Portfoliounternehmen Yellow Jersey Therapeutics wird für USD 1.25 Milliarden übernommen
News Preview
Bestätigung für die wegweisenden Wissenschaft und Innovation des Schweizer Biotech-Unternehmens;
Transaktion erhöht den NAV pro HBM-Aktie um CHF 8.70 (+3,5%); erwarteter Mittelzufluss von USD 78 Millionen für HBM Healthcare Investments.
HBM Healthcare Investments (SIX: HBMN) gab heute bekannt, dass Yellow Jersey Therapeutics, eine Portfoliogesell......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
HBMN
LISTED
SIX
HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
News Preview
Validation for the pioneering science and innovation of the Swiss biotech company;
Transaction increases NAV per HBM share by CHF 8.70 (+3.5%); expected cash inflow of USD 78 million for HBM Healthcare Investments.
HBM Healthcare Investments (SIX: HBMN) today announced that Yellow Jersey Therapeutics, a portfolio company......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
HBMN
LISTED
SIX
HBM-Portfoliounternehmen Yellow Jersey Therapeutics wird für USD 1.25 Milliarden übernommen
News Preview
Bestätigung für die wegweisenden Wissenschaft und Innovation des Schweizer Biotech-Unternehmens;
Transaktion erhöht den NAV pro HBM-Aktie um CHF 8.70 (+3,5%); erwarteter Mittelzufluss von USD 78 Millionen für HBM Healthcare Investments.
HBM Healthcare Investments (SIX: HBMN) gab heute bekannt, dass Yellow Jersey Therapeutics, eine Portfoliogesell......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
HBMN
LISTED
SIX
HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
News Preview
Validation for the pioneering science and innovation of the Swiss biotech company;
Transaction increases NAV per HBM share by CHF 8.70 (+3.5%); expected cash inflow of USD 78 million for HBM Healthcare Investments.
HBM Healthcare Investments (SIX: HBMN) today announced that Yellow Jersey Therapeutics, a portfolio company......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.05.2024
HBMN
LISTED
SIX
HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
News Preview
HBM Healthcare Investments AG
/ Key word(s): Acquisition
HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
22.05.2024 / 18:17 CET/CEST
Swixx BioPharma, the largest investment in the private equity portfolio of HBM Healthcare Investment......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.05.2024
HBMN
LISTED
SIX
HBM Healthcare Investments’ Portfoliounternehmen Swixx BioPharma stärkt Umsatz und Gewinn durch strategische Übernahme in Lateinamerika
News Preview
HBM Healthcare Investments AG
/ Schlagwort(e): Ankauf
HBM Healthcare Investments’ Portfoliounternehmen Swixx BioPharma stärkt Umsatz und Gewinn durch strategische Übernahme in Lateinamerika
22.05.2024 / 18:17 CET/CEST
Swixx BioPharma, die grösste Beteiligung im Private-Equity-Portfolio der HBM Healthcare Investments, ......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.05.2024
HBMN
LISTED
SIX
HBM Healthcare Investments’ Portfoliounternehmen Swixx BioPharma stärkt Umsatz und Gewinn durch strategische Übernahme in Lateinamerika
News Preview
HBM Healthcare Investments AG
/ Schlagwort(e): Ankauf
HBM Healthcare Investments’ Portfoliounternehmen Swixx BioPharma stärkt Umsatz und Gewinn durch strategische Übernahme in Lateinamerika
22.05.2024 / 17:46 CET/CEST
Swixx BioPharma, die grösste Beteiligung im Private-Equity-Portfolio der HBM Healthcare Investments, ......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.05.2024
HBMN
LISTED
SIX
HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
News Preview
HBM Healthcare Investments AG
/ Key word(s): Acquisition
HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
22.05.2024 / 17:46 CET/CEST
Swixx BioPharma, the largest investment in the private equity portfolio of HBM Healthcare Investment......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.05.2024
HBMN
LISTED
SIX
Key Figures
15.05.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.05.2024
16.05.2024 / 17:47 CET/CEST
in CHF
Performance in %
15.05.2024
MTD
FYTD
CYTD
NAV
252.23
-1.0
1.7
......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.05.2024
HBMN
LISTED
SIX
HBM Healthcare Investments erzielt im Geschäftsjahr 2023/2024 ein ausgeglichenes Ergebnis
News Preview
Geringer Verlust von CHF 1 Million
Innerer Wert pro Aktie (NAV) nach Aktienrückkäufen um 0.3% höher
Portfolioentwicklung uneinheitlich
Ungünstige Währungsentwicklungen schmälern Jahresergebnis um rund 2.5%
Portfolio mit Beteiligungen an zwei privaten Unternehmen selektiv ergänzt
Verwaltungsrat beantragt Nennwertrückzahlung von unverändert CHF......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.05.2024
HBMN
LISTED
SIX
HBM Healthcare Investments achieves a balanced result in the 2023/2024 financial year
News Preview
Slight loss of CHF 1 million
Net asset value per share (NAV) 0.3% higher after share buy-backs
Mixed portfolio performance
Unfavourable currency developments reduce annual result by around 2.5%
Portfolio selectively supplemented with investments in two private companies
Board of Directors proposes unchanged par value repayment of CHF 7.50 per......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.05.2024
HBMN
LISTED
SIX
Key Figures
30.04.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
30.04.2024
01.05.2024 / 17:47 CET/CEST
in CHF
Performance in %
30.04.2024
MTD
FYTD
CYTD
NAV
254.66
2.6
2.6
......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.04.2024
HBMN
LISTED
SIX
Key Figures
15.04.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.04.2024
16.04.2024 / 17:47 CET/CEST
in CHF
Performance in %
15.04.2024
MTD
FYTD
CYTD
NAV
242.82
-2.1
-2.1
......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.04.2024
HBMN
LISTED
SIX
Key Figures
31.03.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
31.03.2024
02.04.2024 / 17:48 CET/CEST
in CHF
Performance in %
31.03.2024
MTD
FYTD
CYTD
NAV
248.10
0.4
0.3
......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.04.2024
HBMN
LISTED
SIX
HBM Healthcare Investments publiziert inneren Wert je Aktie (NAV) von CHF 248.10 per 31. März 2024 und Quartalsgewinn von CHF 156 Millionen
News Preview
HBM Healthcare Investments erzielte im Schlussquartal des Geschäftsjahrs 2023/24 per Ende März einen Gewinn von CHF 156 Millionen. Damit konnte der Verlust aus den ersten neun Monate weitgehend wettgemacht werden. Der innere Wert je Aktie (NAV) stieg um 10.3 Prozent auf CHF 248.10 an.
Von der Quartalsperformance entfallen rund zwei Drittel auf ......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.04.2024
HBMN
LISTED
SIX
HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 248.10 as at 31 March 2024 and quarterly profit of CHF 156 million
News Preview
HBM Healthcare Investments generated a profit of CHF 156 million in the final quarter of the 2023/24 financial year as at the end of March. This largely made up for the loss from the first nine months. The net asset value per share (NAV) rose by 10.3 per cent to CHF 248.10.
Positive currency effects accounted for around two thirds of the quarte......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.03.2024
HBMN
LISTED
SIX
Key Figures
15.03.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.03.2024
18.03.2024 / 17:47 CET/CEST
in CHF
Performance in %
15.03.2024
MTD
FYTD
CYTD
NAV
243.47
-1.4
-1.5
......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.03.2024
HBMN
LISTED
SIX
Key Figures
29.02.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
29.02.2024
01.03.2024 / 17:47 CET/CEST
in CHF
Performance in %
29.02.2024
MTD
FYTD
CYTD
NAV
247.01
7.6
-0.1
......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.02.2024
HBMN
LISTED
SIX
Key Figures
15.02.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.02.2024
16.02.2024 / 17:47 CET/CEST
in CHF
Performance in %
15.02.2024
MTD
FYTD
CYTD
NAV
243.93
6.3
-1.3
......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.02.2024
HBMN
LISTED
SIX
Key Figures
31.01.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
31.01.2024
01.02.2024 / 17:47 CET/CEST
in CHF
Performance in %
31.01.2024
MTD
FYTD
CYTD
NAV
229.55
2.0
......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.01.2024
HBMN
LISTED
SIX
HBM Healthcare Investments publiziert Quartalsbericht per 31. Dezember 2023 und Kennzahlen für die ersten neun Monate des Geschäftsjahrs 2023/2024
News Preview
Berichtsquartal schliesst mit Verlust von CHF 87 Millionen. Für die
9-Monatsperiode summiert sich der Verlust auf CHF 158 Millionen
Ungünstige Währungsentwicklungen ausschlaggebend
Wertentwicklung im Rahmen der Vergleichsindizes
Ungünstige Währungsentwicklungen ziehen HBM Healthcare in die Verlustzone
HBM Healthcare Investments schliesst da......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.01.2024
HBMN
LISTED
SIX
HBM Healthcare Investments publishes Quarterly Report as at 31 December 2023 with key figures for the first nine months of the 2023/2024 financial year
News Preview
Quarter under review closes with a loss of CHF 87 million. For the nine-month period, the loss totalled CHF 158 million
Unfavourable currency developments were the decisive factor
Performance is in line with relevant market indices
Unfavourable currency developments drag HBM Healthcare into the red
HBM Healthcare Investments closed the third ......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.01.2024
HBMN
LISTED
SIX
Key Figures
15.01.2024
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.01.2024
16.01.2024 / 17:47 CET/CEST
in CHF
Performance in %
15.01.2024
MTD
FYTD
CYTD
NAV
229.31
1.9
......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.01.2024
HBMN
LISTED
SIX
HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 225.03 as at 31 December 2023
News Preview
HBM Healthcare Investments closed the 2023 calendar year with a negative performance due to unfavourable currency developments. The net asset value per share (NAV) fell by 8.3 percent to CHF 225.03. The share price declined by 5.4 percent to CHF 182.60. Currency developments had a negative impact of around 9.5 per cent on performance in 2023 (USD -......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.01.2024
HBMN
LISTED
SIX
HBM Healthcare Investments publiziert inneren Wert je Aktie (NAV) von CHF 225.03 per 31. Dezember 2023
News Preview
HBM Healthcare Investments schliesst das Kalendarjahr 2023 aufgrund von ungünstigen Währungsentwicklungen mit einer negativen Performance ab. Der innere Wert je Aktie (NAV) reduzierte sich um 8.3 Prozent auf CHF 225.03. Der Aktienkurs ging um 5.4 Prozent auf CHF 182.60 zurück. Die Währungsentwicklungen belasteten die Performance in 2023 mit rund 9.......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.01.2024
HBMN
LISTED
SIX
Key Figures
31.12.2023
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
31.12.2023
03.01.2024 / 18:13 CET/CEST
in CHF
Performance in %
31.12.2023
MTD
FYTD
CYTD
NAV
225.03
-0.7
-8.7
......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
